[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346350-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346350-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pilra-serves-as-a-diagnostic-and-prognostic-biomarker-and-modulates-the-tumor-immune-microenvironment-and-immunotherapy-response-in-breast-cancer","PILRA serves as a diagnostic and prognostic biomarker and modulates the tumor immune microenvironment and immunotherapy response in breast cancer","","Paired immunoglobulin-like type 2 receptor alpha (PILRA) functions as a membrane-associated receptor in immune regulation, yet its role in breast cancer is insufficiently defined. This study profiles PILRA expression, mutation, and DNA methylation patterns and evaluates impacts on immune infiltration, prognostic relevance, and pathways linked to tumor progression. Findings show altered PILRA levels associate with survival and drug resistance and support its diagnostic and prognostic biomarker potential, including relationships to immunotherapy response.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pilra-serves-as-a-diagnostic-and-prognostic-biomarker-and-modulates-the-tumor-immune-microenvironment-and-immunotherapy-response-in-breast-cancer/346350/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pilra-serves-as-a-diagnostic-and-prognostic-biomarker-and-modulates-the-tumor-immune-microenvironment-and-immunotherapy-response-in-breast-cancer/346350.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is PILRA and why is it relevant to breast cancer research?","Question",{"text":63,"@type":64},"PILRA is a membrane-associated receptor involved in immune regulation and signal transduction. Its expression and functional role in breast cancer were largely unknown, motivating the study.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was PILRA expression, mutation, and methylation analyzed in breast cancer?",{"text":68,"@type":64},"PILRA expression was analyzed using TCGA and GTEx, with protein validation via immunohistochemistry and RT-qPCR in paired tumor and adjacent samples. Mutation profiling used cBioPortal, while methylation and prognostic impact used MethSurv, alongside survival and ROC analyses.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the study find about PILRA’s clinical and immune implications?",{"text":72,"@type":64},"PILRA was upregulated in breast cancer and associated with poor survival and drug resistance. Its methylation downregulated expression and correlated with better prognosis, and PILRA related to immune infiltration and tumor microenvironment composition, supporting biomarker value and links to immunotherapy response.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346350,1790244341,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","TYPE Original Research PUBLISHED 16 January 2026  \nDOI 10.3389/fimmu.2025.1682519  \nOPEN ACCESS  \nEDITED BY  \nDomenico Mallardo,  \nG. Pascale National Cancer Institute Foundation (IRCCS), Italy  \nREVIEWED BY  \nMario Fordellone,  \nUniversità degli Studi della Campania Luigi Vanvitelli, Italy  \nMaria Ingenito,  \nG. Pascale National Cancer Institute Foundation (IRCCS), Italy  \n*CORRESPONDENCE  \nJunxia Chen  \n [chjunxia@126.com](chjunxia@126.com)[ ](chjunxia@126.com)Lei Xing  \n [tiger861220@126.com](tiger861220@126.com)  \n†These authors have contributed equally to this work  \nRECEIVED 09 August 2025  \nREVISED 19 December 2025  \nACCEPTED 29 December 2025  \nPUBLISHED 16 January 2026  \nCITATION  \nShi B, Yang Y, Xing L and Chen J (2026) PILRA serves as a diagnostic and prognostic biomarker and modulates the tumor immune microenvironment and immunotherapy response in breast cancer.  \nFront. Immunol. 16:1682519 .  \ndoi: 10.3389/fimmu.2025.1682519  \nCOPYRIGHT  \n© 2026 Shi, Yang, Xing and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nPILRA serves as a diagnostic and prognostic biomarker and modulates the tumor immune microenvironment and immunotherapy response in breast cancer  \nBowen Shi 1,2†, Yan Yang2†, Lei Xing 1* and Junxia Chen 2*  \n1 Department of Breast and Thyroid Surgery, The First Afﬁliated Hospital of Chongqing Medical University, Chongqing, China, 2 Department of Cell Biology and Genetics, Chongqing Medical University, Chongqing, China  \nBackground: Paired immunoglobulin-like type 2 receptor alpha (PILRA) is a membrane-associated receptor involved in immune regulation and signal transduction. However, its expression and functional role in breast cancer remain largely unknown. This study investigated the expression, mutation, and DNA methylation patterns of PILRA in breast cancer, along with its impact on immune inﬁltration and associated pathways. We also evaluated its potential as a therapeutic target for predicting prognosis and guiding immunotherapy in breast cancer.  \nMethods: PILRA expression in breast cancer was analyzed using TCGA and GTEx datasets. Protein expression in breast cancer and adjacent normal tissues was evaluated by immunohistochemistry, and expression levels were validated by RTqPCR in 50 paired tumor and adjacent tissue samples. cBioPortal was used to assess mutation proﬁles and prognostic relevance. Associations with drug resistance were examined by analyzing relationships to resistance- and sensitivity-related genes. DNA methylation and its prognostic impact were analyzed using MethSurv. The prognostic and diagnostic value of PILRA was evaluated through survival and ROC curve analyses. Single-cell and tissue expression data were obtained from HPA and GTEx, and gene effect score from DepMap. Immune associations were assessed using TISIDB. Gene correlation and protein-protein interaction networks were analyzed via TCGA and STRING, followed by KEGG and GO enrichment.  \nResults: PILRA expression was upregulated in breast cancer tissues and associated with poor survival and drug resistance. We identiﬁed R236M as the dominant mutation site and found that its mutation is linked to improved prognosis. PILRA methylation downregulated its expression and correlated with better prognosis. Survival analysis and ROC curves supported the potential of PILRA as a prognostic biomarker. PILRA was involved in immune inﬁltration and modulated the abundance of various immune cells and the tumor microenvironment, suggesting a role in immune regulation and tissue maintenance . Correlation and enrichment analyses revealed ","cbCaios7fBa3RoCc","https://ap.wps.com/l/cbCaios7fBa3RoCc","pdf",23584656,16,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Key literature context\n## Breast cancer burden and biomarker need\n## Immunotherapy and immune-related biomarkers","[{\"question\":\"What is PILRA and why is it relevant to breast cancer research?\",\"answer\":\"PILRA is a membrane-associated receptor involved in immune regulation and signal transduction. Its expression and functional role in breast cancer were largely unknown, motivating the study.\"},{\"question\":\"How was PILRA expression, mutation, and methylation analyzed in breast cancer?\",\"answer\":\"PILRA expression was analyzed using TCGA and GTEx, with protein validation via immunohistochemistry and RT-qPCR in paired tumor and adjacent samples. Mutation profiling used cBioPortal, while methylation and prognostic impact used MethSurv, alongside survival and ROC analyses.\"},{\"question\":\"What did the study find about PILRA’s clinical and immune implications?\",\"answer\":\"PILRA was upregulated in breast cancer and associated with poor survival and drug resistance. Its methylation downregulated expression and correlated with better prognosis, and PILRA related to immune infiltration and tumor microenvironment composition, supporting biomarker value and links to immunotherapy response.\"}]","PILRA serves as a diagnostic and prognostic biomarker and modulates the tumor immune microenvironment and immunotherapy response in breast cancer | PDF",1790061015,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/948cb827c4079568f19790966de373a5.webp",983,1389,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/609b1cea6198fe58bac45d4db2529ec5.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c141a842ff3ccb0dc3676f7487b96863.webp",981,1386,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a93f2ffd97f90d0208e7578e90685e37.webp",980,1385]